Drug Topics
JANUARY 11, 2024
These findings can help health care professionals develop a family-centered treatment plan for pediatric type 1 diabetes, considered a “family disease” by study authors.
Pharmacy Times
JANUARY 11, 2024
These patients may have a similar genetic susceptibility for type 2 diabetes, although they have an individual risk for GDM independent of the risk of type 2 diabetes.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
JANUARY 11, 2024
A recent study found that reduced drug use was associated with a decrease in cravings, drug seeking behaviors, and depression severity.
STAT
JANUARY 11, 2024
Since having a baby 10 months ago, I’ve learned many things. Chief among them: Pumping sucks. But skipping a session ends up being even more painful. Naturally, I expected navigating the J.P. Morgan Healthcare Conference in San Francisco would be more complicated this year. Somehow, between back-to-back meetings and presentations, I’d have to bust out that abominable contraption and do my thing.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Drug Topics
JANUARY 11, 2024
According to Tyler Miliken, education about prior authorization, along with other insurance processes and policies, is critical for advancing patients down their path to care.
STAT
JANUARY 11, 2024
In the spring of 2020, Jamal Clay , a gifted young man who grew up in the south suburbs of Chicago, died by suicide. He was 19 years old. Jamal’s loved ones describe him as creative and talented, a leader in different youth-focused organizations in his community who supported and cared for those he loved. He was just as brilliant as he was kind.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
JANUARY 11, 2024
Generative AI’s earliest applications in medicine have largely focused on curing not patients, but the plague of productivity physicians lose to digital documentation. Now, research suggests a way that large language models like ChatGPT could benefit both patients and providers: by automatically extracting a patient’s social needs from reams of text in their clinical records.
Pharmacy Times
JANUARY 11, 2024
High intensity interval training (HIIT) showed improved heart failure outcomes compared to medium chain triacylglycerol, used for endurance performance among athletes, and the usual care.
STAT
JANUARY 11, 2024
A preliminary evaluation by the Food and Drug Administration did not find evidence that GLP-1 drugs like Ozempic and Wegovy cause suicidal thoughts or actions. The regulator has been reviewing reports of patients experiencing suicidal ideations while using this class of diabetes and obesity treatments, but because there was limited information provided and because other factors could be influencing the suicidal thoughts, the FDA determined that there was no clear link to the drugs, it said in a
Pharmacy Times
JANUARY 11, 2024
The update includes a recommended triple therapy with belimumab as a first line treatment for class III or IV lupus nephritis following the approvals of belimumab and voclosporin.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT
JANUARY 11, 2024
SAN FRANCISCO — It seemed like there was a point during last year’s J.P. Morgan Healthcare Conference when we all collectively realized, “Oh, 2023 is going to be another slog.” Indeed, a downturn has weighed on the biotech industry for nearly three years. But this January, things feel different. Maybe it’s the abundance of sunlight that filled San Francisco this week.
Pharmacy Times
JANUARY 11, 2024
The data also suggest that further studies investigating a plausible causal relationship between pneumonia and type 1 diabetes are needed.
STAT
JANUARY 11, 2024
My daughter Katie was born with severe disabilities. She went on to develop profound autism, attention deficit disorder, and obsessive-compulsive disorder. The hardest part for her is knowing that she’s different but not understanding how or why. My career as a health care manager and now a researcher has been derailed and fragmented because I have a profoundly disabled daughter who has undergone so many treatments and required special schools.
Pharmacy Times
JANUARY 11, 2024
Variations and conditions included in existing state bills, however, limit the effectiveness of this approach.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Fierce Pharma
JANUARY 11, 2024
Dermavant’s topical cream Vtama, already on the market for plaque psoriasis as a steroid-free treatment, is compiling impressive data in pursuit of an FDA approval in atopic dermatitis (AD). | Dermavant’s topical cream Vtama, already on the market for plaque psoriasis as a steroid-free treatment, is compiling impressive data in pursuit of an FDA approval in atopic dermatitis (AD).
pharmaphorum
JANUARY 11, 2024
Generative AI is revolutionising the pharmaceutical industry, accelerating the speed to market for new drugs. Learn how regulatory processes, R&D, and clinical trials are being impacted by this innovative technology.
Fierce Healthcare
JANUARY 11, 2024
Generative AI models can identify social determinants of health (SDOH) in doctors’ notes, a new study finds. | The study showed that fine-tuned language models could identify the vast majority of patients with an adverse SDOH, which could augment efforts to identify patients who need social support.
pharmaphorum
JANUARY 11, 2024
The FDA is overseeing significant changes in R&D IT as it shifts towards advanced modalities and biologics. This includes the emergence of CRISPR-Cas9 gene editing technology and its potential impact on diseases like sickle cell anaemia. Learn more about these exciting developments in this article.
PharmaVoice
JANUARY 11, 2024
As advanced therapies and patient perspectives strengthen their foothold in R&D, pharma is poised to deliver impactful treatments in record time.
Fierce Healthcare
JANUARY 11, 2024
YouTube has launched a new feature to help users quickly find actionable and easy-to-follow videos for basic first aid and emergency care from authoritative health organizations. | Viewers searching for certain acute health topics can now access short explainer videos at the top of search results from reputable sources, developed in partnership with Mass General Brigham and the Mexican Red Cross.
STAT
JANUARY 11, 2024
Rune Labs, maker of an Apple Watch app that can track symptoms related to Parkinson’s disease, announced Thursday $12 million in funding led by Nexus NeuroTech, a new venture capital fund focused on brain disorders. Rune in 2021 received Food and Drug Administration clearance for StrivePD, an Apple Watch app that uses the device’s sensors to track two Parkinson’s-related symptoms: tremors and dyskinesia, or the involuntary movements that are a side effect of medication.
Fierce Healthcare
JANUARY 11, 2024
Charges for electronic, asynchronous clinician-patient messaging — or e-visits — have persisted in the wake of an early-2020 spike during the COVID-19 pandemic. | After an early 2020 spike, monthly claims for e-visits rose from 64,000 in June 2021 to 107,000 by Sept. 2022. The total number of health systems with at least 50 logged claims also rose about 40% from Q3 2021 to Q3 2022.
Pharmacy Times
JANUARY 11, 2024
At a young age, hands-on learning about nutrition can promote long-term appreciation of fresh food and food experiences.
Fierce Pharma
JANUARY 11, 2024
With sales declining for aging MS drug Fampyra, Biogen has exercised an option to return licensing rights outside of the U.S. to Acorda Therapeutics.
Pharmacy Times
JANUARY 11, 2024
To have skin-deep resilience is to overcome adversity to achieve success, be it psychological or academic.
STAT
JANUARY 11, 2024
The Pashai family of Dallas on Thursday got some good news, but not exactly the news they had spent the last month praying for. The Texas Medicaid program, after denying coverage for an initial consult to begin experimental gene therapy that could save the life of their infant son, Sufyan, now says it will cover the costs for him to be assessed in person by doctors there.
European Pharmaceutical Review
JANUARY 11, 2024
Quotient Sciences leverage more than 30 years of drug development expertise to support small molecule and synthetic peptide drug programmes, in both simple drug programmes as well as complex cases where specialised formulation expertise and technologies are required. All drug development programmes are challenging, with numerous stages that an active, lead molecule or new chemical entity (NCE) must transition through to gain regulatory approval and demonstrate its benefits to patients Find out m
STAT
JANUARY 11, 2024
In honor of JPM Week, you’re reading a special edition of our biotech newsletter, The Readout. To stay on top of the latest scoops and live reporting from the San Francisco conference, join our newsletter list. JPM Week is finally drawing to a close, sending the drug industry’s many financiers scattering from San Francisco to their respective homes and ski destinations.
Drug Store News
JANUARY 11, 2024
AirLight Pro, developed in partnership with Zuvi, uses a combination of infrared-light technology and wind to dry the hair for a smoother and hydrated look and feel, the company stated.
European Pharmaceutical Review
JANUARY 11, 2024
The European Commission (EC) has granted a marketing authorisation for Uzpruvo ® (AVT04) in Europe, a biosimilar candidate to Stelara ® (ustekinumab). Ustekinumab biologic Once the European Supplementary Protection Certificate (SPC) for Stelara expires in July 2024, this will open up market entry as soon as possible for Uzpruvo, now that it is approved in Europe” Ustekinumab is a human IgG1κ monoclonal antibody (mAb).
Fierce Healthcare
JANUARY 11, 2024
Enrollment in individual market coverage continues to grow, and insurers are expressing concern about their ability to tailor coverage to different populations given limits on nonstandard plan opti | Enrollment in individual market coverage continues to grow, and insurers are expressing concern about their ability to tailor coverage to different populations given limits on nonstandard plan options.
Hospital Pharmacy Europe
JANUARY 11, 2024
A recent multidisciplinary report concluded that significant gaps currently exist in consistent education and training on fluid management, and innovative solutions are needed to drive change and transformation. 1 Healthcare institutions should therefore implement programmes on fluid stewardship to achieve their quality improvement and patient safety goals.
pharmaphorum
JANUARY 11, 2024
In this new episode of the pharmaphorum podcast, host Nicole Raleigh speaks with James Burt, CEO of Pharmanovia, about the value-added medicines space.
STAT
JANUARY 11, 2024
Is biotech back from its downturn? Can Nvidia solve biology? And is it wise to do a deal on a party bus? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Recording from the J.P. Morgan Healthcare Conference, we discuss how a spate of deals and some intermittent sunshine seem to have brightened the outlook for biotech at the outset of 2024.
Expert insights. Personalized for you.
185 
Let's personalize your content